Karen Bluemke

Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Renal Cell Carcinoma Correlates with Prognosis

Karen Bluemke, Udo Bilkenroth, Axel Meye et al. · Cancer Epidemiology Biomarkers & Prevention · 2009 · 82 citations

Medicine, Oncology, Pathology +17

Alterations of cancer‐related genes in soft tissue sarcomas: Hypermethylation of <i>RASSF1A</i> is frequently detected in leiomyosarcoma and associated with poor prognosis in sarcoma

Claudia Seidel, Frank Bartel, Matthias Rastetter et al. · International Journal of Cancer · 2004 · 53 citations · Full text

Medicine, Genetics, Oncology +14

Differences in the frequencies of HLA-class I and II alleles between German patients with renal cell carcinoma and healthy controls

Steffen Goebel, Astrid Kehlen, Karen Bluemke et al. · Cancer Immunology Immunotherapy · 2017 · 21 citations · Full text

Life Sciences, Genetics, Immunology +17

Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasis

Susanne Fuessel, Kati Erdmann, Helge Täubert et al. · BMC Cancer · 2014 · 13 citations · Full text

Medicine, Oncology, Pathology +17